1. Thakkar, R, Sareddy, G R, Zhang, Q, Vadlamudi, R K, Brann, D. . PELP1: a key mediator of oestrogen signalling and actions in the brain. In Journal of neuroendocrinology, 30, . doi:10.1111/jne.12484. https://pubmed.ncbi.nlm.nih.gov/28485080/
2. Sareddy, Gangadhara Reddy, Vadlamudi, Ratna K. 2016. PELP1: Structure, biological function and clinical significance. In Gene, 585, 128-134. doi:10.1016/j.gene.2016.03.017. https://pubmed.ncbi.nlm.nih.gov/26997260/
3. Altwegg, Kristin A, Pratap, Uday P, Liu, Zexuan, Rao, Manjeet K, Vadlamudi, Ratna K. 2023. Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34. In Breast cancer research and treatment, 200, 151-162. doi:10.1007/s10549-023-06958-4. https://pubmed.ncbi.nlm.nih.gov/37199805/
4. Brann, Darrell W, Zhang, Quan-Guang, Wang, Rui-Min, Mahesh, Virendra B, Vadlamudi, Ratna K. 2008. PELP1--a novel estrogen receptor-interacting protein. In Molecular and cellular endocrinology, 290, 2-7. doi:10.1016/j.mce.2008.04.019. https://pubmed.ncbi.nlm.nih.gov/18571832/
5. Vuttaradhi, Veena Kumari, Ezhil, Inemai, Ramani, Divya, Venkatraman, Ganesh, Rayala, Suresh Kumar. 2021. Inflammation-induced PELP1 expression promotes tumorigenesis by activating GM-CSF paracrine secretion in the tumor microenvironment. In The Journal of biological chemistry, 298, 101406. doi:10.1016/j.jbc.2021.101406. https://pubmed.ncbi.nlm.nih.gov/34774800/
智鼠故事 
